Autolus Therapeutics News

Buy Rating on Autolus Therapeutics: Innovative Cancer Treatments and Strategic Leadership Drive Positive Outlook

TipRanksApr 12 06:06 ET

Autolus Therapeutics Analyst Ratings

BenzingaApr 12 06:00 ET

Autolus Therapeutics Analyst Ratings

BenzingaApr 9 13:40 ET

Truist Securities Adjusts Price Target on Autolus Therapeutics to $10 From $9, Keeps Buy Rating

MT NewswiresMar 18 09:55 ET

Autolus Therapeutics Analyst Ratings

BenzingaMar 18 09:44 ET

Buy Rating Affirmed for Autolus Therapeutics Amid Strong Progress and Potential of Obe-cel

TipRanksMar 15 05:16 ET

Analysts Offer Insights on Healthcare Companies: Cullinan Management (CGEM), Coherus Biosciences (CHRS) and Autolus Therapeutics (AUTL)

TipRanksMar 14 13:40 ET

Autolus Therapeutics Analyst Ratings

BenzingaFeb 12 06:33 ET

Neutral Outlook for Autolus Therapeutics Amid BioNTech Collaboration and Reduced M&A Speculation

TipRanksFeb 8 17:35 ET

Wells Fargo Gives a Buy Rating to Autolus Therapeutics (AUTL)

TipRanksJan 23 06:08 ET

Buy Rating Reiterated for Autolus Therapeutics Amid Positive Regulatory Developments and Growth Potential

TipRanksJan 22 14:47 ET

Autolus Therapeutics Analyst Ratings

BenzingaJan 22 13:07 ET

Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Masimo (MASI)

TipRanksJan 11 05:13 ET

Goldman Sachs Maintains Neutral on Autolus Therapeutics, Raises Price Target to $4.8

BenzingaDec 13, 2023 09:32 ET

Autolus Therapeutics Analyst Ratings

BenzingaDec 13, 2023 09:31 ET

Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), Autolus Therapeutics (AUTL) and Vaxcyte (PCVX)

TipRanksDec 13, 2023 02:30 ET

Needham Reiterates Buy on Autolus Therapeutics, Maintains $7 Price Target

BenzingaNov 29, 2023 05:50 ET

Analysts' Top Healthcare Picks: Autolus Therapeutics (AUTL), Amphastar Pharmaceuticals (AMPH)

TipRanksNov 29, 2023 05:50 ET

Autolus Therapeutics Analyst Ratings

BenzingaNov 29, 2023 05:48 ET

Autolus Therapeutics: Strong Buy Rating Affirmed Amid Promising Pipeline and Strategic Milestones

TipRanksNov 29, 2023 01:36 ET